Suppr超能文献

对黏附于胶原蛋白或血浆凝块的血小板的促凝血活性。

Procoagulant activity on platelets adhered to collagen or plasma clot.

作者信息

Ilveskero S, Siljander P, Lassila R

机构信息

Wihuri Research Institute and Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):628-35. doi: 10.1161/01.atv.21.4.628.

Abstract

In a new 2-stage assay of platelet procoagulant activity (PCA), we first subjected gel-filtered platelets to adhesion on collagen (as a model of primary hemostasis) or plasma clots (as a model of preformed thrombus) for 30 minutes, and then the adherent platelets were supplemented with pooled, reptilase-treated, diluted plasma. Defibrinated plasma provided coagulation factors for assembly on platelet membranes without uncontrolled binding of thrombin to fibrin(ogen). Platelet adhesion to both surfaces showed modest individual variation, which increased at platelet densities that allowed aggregation. However, adhesion-induced PCA varied individually and surface-independently >3-fold, suggesting a uniform platelet procoagulant mechanism. Permanently adhered platelets showed markedly enhanced PCA when compared with the platelet pool in suspension, even after strong activation. The rate of thrombin generation induced by clot-adherent platelets was markedly faster than on collagen-adherent platelets during the initial phase of coagulation, whereas collagen-induced PCA proceeded slowly, strongly promoted by tissue thromboplastin. Therefore at 10 minutes, after adjustment for adhered platelets, collagen supported soluble thrombin formation as much as 5 times that of the thrombin-retaining clots. Activation of platelets by their firm adhesion was accompanied by formation of microparticles, representing about one third of the total soluble PCA. Collagen-adhered platelets provide soluble thrombin and microparticles, whereas the preformed clot serves to localize and accelerate hemostasis at the injury site, with the contribution of retained thrombin and microparticles.

摘要

在一项新的血小板促凝血活性(PCA)两阶段检测中,我们首先将凝胶过滤后的血小板置于胶原蛋白(作为初级止血模型)或血浆凝块(作为预先形成的血栓模型)上粘附30分钟,然后向粘附的血小板中加入混合的、经蛇毒凝血酶处理的稀释血浆。去纤维蛋白血浆提供凝血因子,以便在血小板膜上组装,同时避免凝血酶与纤维蛋白(原)不受控制地结合。血小板在这两种表面上的粘附表现出适度的个体差异,在允许聚集的血小板密度下这种差异会增加。然而,粘附诱导的PCA个体差异较大且与表面无关,相差超过3倍,这表明存在统一的血小板促凝血机制。与悬浮状态的血小板池相比,即使在强烈激活后,永久粘附的血小板仍显示出明显增强的PCA。在凝血初始阶段,凝块粘附的血小板诱导凝血酶生成的速度明显快于胶原蛋白粘附的血小板,而胶原蛋白诱导的PCA进展缓慢,受组织凝血活酶强烈促进。因此,在10分钟时,在对粘附血小板进行调整后,胶原蛋白支持的可溶性凝血酶形成量是保留凝血酶的凝块的5倍。血小板通过牢固粘附而被激活时伴随着微粒的形成,微粒约占总可溶性PCA的三分之一。胶原蛋白粘附的血小板提供可溶性凝血酶和微粒,而预先形成的凝块则有助于在损伤部位定位并加速止血,同时保留凝血酶和微粒也发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验